慢性肺炎2.0:支气管扩展剂,生物药物及其他 - - 一项系统性审查
Huda Shamim1, Anil Kumar Singh, Rahul Sharma
1Department of Pulmonary Medicine, Chandan Hospital, Lucknow, Uttar Pradesh, India.
Lung India : official organ of Indian Chest Society
|December 31, 2025
概括
生物疗法对慢性阻塞性肺部疾病 (COPD) 有前途,特别是在患有eosinophilic表型的患者中. 这些治疗方法可以减少恶化并改善生活质量,提供一种新的个性化管理方法.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种进展性呼吸道疾病,具有持续的空气流量限制和炎症.
- 像支气管扩展剂这样的传统治疗方法也有局限性,许多患者患有无法控制的疾病.
- 乙性COPD表型代表了一个可能受益于向治疗的子组.
研究的目的:
- 系统地审查生物剂在COPD管理中的疗效,安全性和临床影响.
- 评估COPD的新型治疗方法,重点是个性化医学.
- 评估生物制剂对特定的COPD表型,特别是eosinophilic表型的影响.
主要方法:
- 在PubMed,Scopus和Cochrane图书馆进行全面的文献搜索,截至2025年3月.
- 包括随机对照试验,队列研究和对生物治疗的真实世界的证据.
- 专注于评估针对异性炎症的单克隆抗体的研究 (例如,抗IL-5,抗IL-4/13).
主要成果:
- 生物疗法,包括抗介质素 (IL) - 5和抗IL - 4/13药物,在COPD亚组中显示出显著的益处,这些亚组具有高的乙素细胞数量和频繁的恶化.
- 这些治疗与减少恶化率和改善生活质量得分有关.
- 这些生物制剂在COPD患者中的安全性概况通常是可以接受的.
结论:
- 生物疗法代表了个性化COPD管理的重大进步,特别是对于eosinophilic表型.
- 这些新的治疗方法为COPD患者提供了新的前沿,尽管传统疗法无法控制COPD.
- 需要进一步的研究来确定长期的安全性,成本效益和生物制剂在COPD中的更广泛适用性.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
698
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
698
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K